Sell sideSector: Healthcare BUSINESS DESCRIPTIONSpecialist mole treatment provider. DATE:August 2024 SITUATION- A&M was introduced to a group of skincare and cosmetic surgery companies, operating as the Sk:n group (“the Group”). We were introduced as the Group was loss making and experiencing liquidity challenges.
A&M ROLE AND OUTCOMEOur engagement with the Group involved a cash flow review, contingency planning and latterly an accelerated M&A process. The sale process commenced in July-24. As a result of the sale process, several offers were received to acquire the shares of the Company on a standalone basis via a solvent transaction. Upon receiving final bids, A&M were retained to progress the sale of the Company’s shares to the preferred buyer via a Fixed Charge Receivership. A&M assisted with the carve-out of the Company from the Group to execute the share sale to a buyer backed by Palatine Private Equity. The sale completed in August 2024.
|
